Shortly, Dr. Kai Lamottke has given an interview to Pharma Board room and disclosed the development of the company over the past 20 years in Germany and China: The success of business idea and promising anti-seizure drug as well as …
Medicinal Chemistry & Synthesis: Bicoll seamlessly guides your synthesis and lead optimization projects through drug discovery and development with intensive understanding of structure-activity relationships, capability in biological data interpretation, solid knowledge of intellectual property and patent aspects. Reliable and fast reporting …
Product development candidates into your drug discovery projects: Intelligent screening with Bicoll Profiles™ – innovative techniques, methods and equipment accompanied with the extensive experience and expertise of our scientists in natural product chemistry. Bicoll Plant Profiles™ give you access to …
Eisenach, Germany, May 21 – 24, 2019 Cutting-edge research in taste and smell returns once more to the beautiful “Hotel on the Wartburg” in Eisenach, Germany. Since its inception in 1978, the Wartburg Symposium on Flavor Chemistry & Biology has …
Tsukuba, Ibaraki – Bicoll presents at Ibaraki Business conference, February 19-20, 2019 On February 19 (Tue.) and 20 (Wed.), 2019, the Ministry of Economy, Trade and Industry (METI), the Japan External Trade Organization (JETRO) and Ibaraki Prefecture will jointly hold …
Kawasaki, Kanagawa, February 8 2019 – Bicoll joins RINK Festival 2019 with video presentation. RINK is a network that has been established for the purpose of creating innovation by companies located in the Life Innovation Center (LIC), a center located …
Bicoll brings in its medicinal chemistry competence as an active participant of EpimiRNA project. A first novel lead structure preventing seizures in a human tissue model could be provided through the consortium efforts. Furthermore, there are a number of results …
China Biotech revolution, special edition: “Bicoll is the first German-Chinese biotech company.” (Dr. Kai Lamottke, Bicoll GmbH, CEO). Those who missed the printed version – order the e-paper in German or Chinese PDF Download (German)
5 years of collaborative work with 16 partners under the 7th Framework Programme have been finished with the great results and desire to work further on epilepsy. Bicoll small molecule appeared to be reducing the epileptic seizures and miRNA can …
医薬、医療から研究機器、設備、エネルギーまで！バイオ産業の「今」が集結！ On the 9th of October Bicoll participates in 欧州のライフサイエンス企業との商談会 in Osaka 2018 European Biotech and Pharma Partnering Conference, Osaka 2018 From 10th till 12th of October Bicoll will exhibit under the umbrella of GermanPavilion (Partnering meetings are also available) @ …